FDA information regarding Biosimilars

Posted in Latest News on August 26, 2013.

The FDA has created a pathway for the approval of biosimilar products, but has not yet approved a biological product as biosimilar or interchangeable. There is no date-certain for when these products will be approved—some estimates are three to five years.
The Board of Pharmacy has established a link on its website to the FDA pathway for approval of biosimilar biological products.



More Latest News

Bills That Go Into Effect January 1, 2017
February 17, 2017

SB 0422 Relating to Health Insurance Coverage For Opioids Health Insurance Coverage For Opioids; Providing that a health insurance policy that covers abuse-deterrent opioid analgesic drug products may impose a prior authorization requirement for an abuse-deterrent opioid analgesic drug product … Continue reading


DEA’s suspension of McKesson Corporation Retraction
January 19, 2017

Please see updated information about the DEA’s suspension of McKesson Corporation and controlled substances Continue reading